
Ranked as the 7th largest Indian pharmaceutical company, this company operates its own R&D, bioequivalence center, and API and finished dosage manufacturing sites, approved by the US FDA, MHRA and others. Its product range spans CVS, CNS, anti-diabetic, anti-HIV, anti-TB, anti-asthmatic and anti-malarial products, with a presence across 110 countries and subsidiaries in the USA, UK, Spain, South Africa, Ukraine and Kazakhstan, offering EU marketing authorizations and out-licensing of US/EU CTD dossiers with FDF/API supply.

댓글이 없습니다.
평가 & 댓글 남기기